Deciding priorities in Pharma

Good pharma? Bad pharma? Better pharma.

Pharma Workgroup

A. People: Project Leader: Ana Belén Elgoyhen, Ph.D., Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina. Principal Investigators: Clinical Trials • Otosul-Otorrinolaringología, Volta Redonda, Brazil, Andreia Azevedo, M.D. • Otosul-Otorrinolaringología, Volta Redonda, Brazil, Ricardo Figui...

What reasons do those with practical experience use in deciding on priorities for healthcare resources? A qualitative study.

BACKGROUND Priority setting is necessary in current healthcare services. Discussion of fair process has highlighted the value of developing reasons for allocation decisions on the basis of experience gained from real cases. AIM To identify the reasons that those with experience of real decision-making concerning resource allocation think relevant in deciding on the priority of a new but expen...

What's Trending in Pharma IT?

Challenging pharmaceutical manufacturers everywhere, every day are the myriad issues surrounding the acquisition, disposition and analysis of the huge amounts of data their operations create around the clock. Any Pharma producer worth its salt these days is likely investing a great deal of time, resources and effort to create or maintain a comprehensive information technology (IT) infrastructur...

Big Pharma (The Play)

A nyone who has experienced the assault of the pharmaceutical industry's marketing campaigns would appreciate Jennifer Berry's one-person play Big Pharma: The Rise of the Anti-Depressant Drug Industry and the Loss of a Generation. Since the mid-1990s, spending on drug promotion has grown steadily, reaching $21 billion in 2002. Berry explores the fallout of this expanded marketing blitz through ...